These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
886 related articles for article (PubMed ID: 14614898)
21. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease. Hartman RE; Laurer H; Longhi L; Bales KR; Paul SM; McIntosh TK; Holtzman DM J Neurosci; 2002 Dec; 22(23):10083-7. PubMed ID: 12451108 [TBL] [Abstract][Full Text] [Related]
22. Brain area- and isoform-specific inhibition of synaptic plasticity by apoE4. Levi O; Jongen-Relo AL; Feldon J; Michaelson DM J Neurol Sci; 2005 Mar; 229-230():241-8. PubMed ID: 15760646 [TBL] [Abstract][Full Text] [Related]
23. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease. Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894 [TBL] [Abstract][Full Text] [Related]
24. ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro. Nwabuisi-Heath E; Rebeck GW; Ladu MJ; Yu C ASN Neuro; 2014 Jan; 6(1):e00134. PubMed ID: 24328732 [TBL] [Abstract][Full Text] [Related]
25. Isoform-specific effects of apoE on neurite outgrowth in olfactory epithelium culture. Hussain A; Luong M; Pooley A; Nathan BP J Biomed Sci; 2013 Jul; 20(1):49. PubMed ID: 23845000 [TBL] [Abstract][Full Text] [Related]
26. Expression of human apolipoprotein E downregulates amyloid precursor protein-induced ischemic susceptibility. Koistinaho M; Kettunen MI; Holtzman DM; Kauppinen RA; Higgins LS; Koistinaho J Stroke; 2002 Jul; 33(7):1905-10. PubMed ID: 12105373 [TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease. Butterfield DA; Mattson MP Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033 [TBL] [Abstract][Full Text] [Related]
28. Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2. Klein RC; Mace BE; Moore SD; Sullivan PM Neuroscience; 2010 Dec; 171(4):1265-72. PubMed ID: 20951774 [TBL] [Abstract][Full Text] [Related]
29. Reducing human apolipoprotein E levels attenuates age-dependent Aβ accumulation in mutant human amyloid precursor protein transgenic mice. Bien-Ly N; Gillespie AK; Walker D; Yoon SY; Huang Y J Neurosci; 2012 Apr; 32(14):4803-11. PubMed ID: 22492035 [TBL] [Abstract][Full Text] [Related]
30. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology. Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060 [TBL] [Abstract][Full Text] [Related]
31. ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Levi O; Jongen-Relo AL; Feldon J; Roses AD; Michaelson DM Neurobiol Dis; 2003 Aug; 13(3):273-82. PubMed ID: 12901842 [TBL] [Abstract][Full Text] [Related]
32. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. Sun Y; Wu S; Bu G; Onifade MK; Patel SN; LaDu MJ; Fagan AM; Holtzman DM J Neurosci; 1998 May; 18(9):3261-72. PubMed ID: 9547235 [TBL] [Abstract][Full Text] [Related]
33. The detrimental effects of APOE4 on risk for Alzheimer's disease may result from altered dendritic spine density, synaptic proteins, and estrogen receptor alpha. Taxier LR; Philippi SM; York JM; LaDu MJ; Frick KM Neurobiol Aging; 2022 Apr; 112():74-86. PubMed ID: 35051676 [TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. Sheng H; Laskowitz DT; Bennett E; Schmechel DE; Bart RD; Saunders AM; Pearlstein RD; Roses AD; Warner DS J Cereb Blood Flow Metab; 1998 Apr; 18(4):361-6. PubMed ID: 9538900 [TBL] [Abstract][Full Text] [Related]
35. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis. Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508 [TBL] [Abstract][Full Text] [Related]
36. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062 [TBL] [Abstract][Full Text] [Related]
37. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Colton CA; Brown CM; Cook D; Needham LK; Xu Q; Czapiga M; Saunders AM; Schmechel DE; Rasheed K; Vitek MP Neurobiol Aging; 2002; 23(5):777-85. PubMed ID: 12392781 [TBL] [Abstract][Full Text] [Related]
40. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging. Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]